[HTML][HTML] … trans-resveratrol on insulin resistance, inflammation, and microbiota in men with the metabolic syndrome: A pilot randomized, placebo-controlled clinical trial

JM Walker, P Eckardt, JO Aleman… - … translational research, 2019 - ncbi.nlm.nih.gov
… acetylate and activate or deactivate many substrates, including Forkhead transcription factor
study was to determine if high dose RES, administered to obese men with insulin resistance

[HTML][HTML] No effect of resveratrol supplementation after 6 months on insulin sensitivity in overweight adults: A randomized trial

M de Ligt, M Bergman, RM Fuentes, H Essers… - … journal of clinical …, 2020 - Elsevier
… Pre- and postintervention, energy expenditure and substraterandomized, placebo-controlled,
parallel-group clinical trial, … effects of resveratrol on body composition compared with …

… of resveratrol supplementation on hepatic steatosis and cardiovascular indices in overweight subjects with type 2 diabetes: a double-blind, randomized controlled trial

A Ali Sangouni, S Abdollahi… - BMC cardiovascular …, 2022 - Springer
… blood glucose and decreased insulin sensitivity [3]. Non-alcoholic fatty liver disease (NAFLD) …
A double-blind, placebo-controlled, single-center, randomized clinical trial with two parallel …

[HTML][HTML] … metabolism, insulin resistance, inflammation, and renal function in the elderly patients with type 2 diabetes mellitus: A randomized controlled clinical trial …

N Ma, Y Zhang - Medicine, 2022 - journals.lww.com
… A randomized parallel placebo-controlled clinical trial among … Poulsen et al [ 23 ] demonstrated
that high-dose resveratrol (… not considerably impact liver fat content or cardiometabolic …

[HTML][HTML] Oral resveratrol supplementation improves Metabolic Syndrome features in obese patients submitted to a lifestyle-changing program

GC Batista-Jorge, AS Barcala-Jorge, MF Silveira… - Life sciences, 2020 - Elsevier
… A randomized clinical trial, double-blind, placebo controlled, performed with 24 patients with
MetS showed that resveratrol was able to decrease weight, BMI, fat … and insulin sensitivity in …

Implications of resveratrol in obesity and insulin resistance: a state-of-the-art review

TM Barber, S Kabisch, HS Randeva, AFH Pfeiffer… - Nutrients, 2022 - mdpi.com
… In a randomized, placebo-controlled crossover study in … energy and metabolic status, the
presence of SIRT1 substrates, … 140 human clinical trials, the metabolic benefits of resveratrol in …

The role of resveratrol administration in human obesity

LM Mongioì, S La Vignera, R Cannarella… - International journal of …, 2021 - mdpi.com
… dose of resveratrol (300 mg per day), and the third a high dose of … randomized, placebo-controlled
clinical trial on the effects of … content, body composition, blood pressure, resting energy …

Effect of resveratrol supplementation on lipid profile in subjects with dyslipidemia: A randomized double-blind, placebo-controlled trial

LE Simental-Mendía, F Guerrero-Romero - Nutrition, 2019 - Elsevier
… , a randomized double-blind, placebo-controlled clinical trial was … and obese individuals [21],
in agreement with our results. … lipid metabolism, the antiatherosclerotic activity of resveratrol

Resveratrol for weight loss in obesity: an assessment of randomized control trial designs in ClinicalTrials. gov

A Hillsley, V Chin, A Li, CS McLachlan - Nutrients, 2022 - mdpi.com
metabolic outcomes including insulin resistance, body weight, … For the high dose category,
21.4 mg/kg at BMI 23 and 12.3 … weight, waist circumference, BMI and body composition as the …

Can resveratrol supplement change inflammatory mediators? A systematic review and meta-analysis on randomized clinical trials

F Haghighatdoost, M Hariri - European journal of clinical nutrition, 2019 - nature.com
Resveratrol might improve insulin resistance by inflammation … separately on male and female
with obesity and consideration … Assessing resveratrol effect on body composition together …